￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The LUPER study evaluates rubicatin/rubitin combined with pembrolizumab in the treatment of relapsed small cell lung cancer

2026-02-01 22:25:32

Check Details
Is Pirfenidone/Isrifenidone a hormonal drug? Analysis of pharmacological effects and treatment principles

2026-02-01 22:25:32

Check Details
How much does a box of 2025 Sotoraxibu cost? Latest market prices and purchasing methods

2026-02-01 22:25:32

Check Details
Usage and dosage of adagrasib: How to use medicine scientifically to improve efficacy

2026-02-01 22:25:32

Check Details
How much does a box of Afatinib cost in 2025? Full analysis of the latest prices and medical insurance reimbursement

2026-02-01 22:25:32

Check Details
The main functions and functions of Dali Leisheng Tablets and a complete analysis of its indications

2026-02-01 22:25:32

Check Details
Which company develops and produces Lynparib/Olaparib? Brand and global supply analysis

2026-02-01 22:25:32

Check Details
How effective is venetoclax/venetoclax? New hope for leukemia patients

2026-02-01 22:25:32

Check Details
What kind of medicine is Acemini? New hope for leukemia patients

2026-02-01 22:25:32

Check Details
What is the mechanism of action of ritexitinib? Analysis of main functions and indications

2026-02-01 22:25:32

Check Details
Ixazomib/Enleri medical insurance price analysis: latest price and reimbursement policy in 2025

2026-02-01 22:25:32

Check Details
Rubicatin/rubitin withdraw from small cell lung cancer clinical trial? Reasons behind and future prospects

2026-02-01 22:25:32

Check Details
Category
相关知识